| Amgen Switzerland AG - Aranesp 300 Mikrogramm, Injektionslösung in Fertigspritze |
| 55725 | | 11 | | Aranesp 300 Mikrogramm | | Injektionslösung in Fertigspritze | | B03XA02 | | Darbepoetin Alfa | | 13.09.2002 | | |
|
| Composition |
| darbepoetinum alfa 300 µg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.6 ml corresp., natrium 2.27 mg. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Darbepoetin Alfa | 300µg / 0.6ml |
| | BAG: Active Agent | Dose |
|---|
| Darbepoetin Alfa | 0.3 mg |
| | | | Inactive agents |
|---|
| Disodium Phosphate | | Sodium Chloride | | Sodium Dihydrogenophosphate Monohydrate | | Polysorbatum 80 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 071 | syringe(s) | 628.29 | 699.70 | A | SL | No |
|
